The development of novel biotechnologies will be a key component of the economic growth and development of Canadas changing economy. A critical component of this will be fostering the development of start-up companies that can capitalize on these new opportunities. The Myera Group is an indigenous-led company in Manitoba that is developing novel biotechnologies for Canadas new economy. This project focuses on the development of microorganisms that can produce a profile of novel high-value carotenoids (chemically related to ?-carotene).
Astaxanthin is a high-value natural product that is produced by a number of strains of algae. Astaxanthin and related carotenoids such as leutein and zeaxanthin, all derived from beta-carotene, have been demonstrated to have positive health benefits when taken as a dietary supplement. The Myera Group, a Manitoba biotechnology start-up company, has as a primary goal the production of astaxanthin for the commercial market.